Formulation and evaluation of verapamil hydrochloride osmotic controlled release matrix tablets

Main Article Content

S. Vidyadhara
R. L. C. Sasidhar
V. Uma Maheswara Rao
C. H. Showri Babu
D. Lakshmi Harika


Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the controlled delivery
of drugs, independent of pH and hydrodynamic conditions of gastrointestinal tract (GIT). The present study was
aimed to develop osmotic controlled extended release formulations of verapamil hydrochloride an angiotensin II receptor antagonist with anti‑hypertensive activity. Verapamil hydrochloride matrix tablets were prepared by direct compression process using hydroxypropyl methylcellulose (HPMC) K 15M as polymeric material and mannitol as osmogen at varied concentrations. The matrix tablets were further coated with different compositions of ethylcellulose7cps and polyethylene glycol (PEG)‑4000 by pan coating method. Physical parameters such as weight uniformity, drug content, hardness and friability were evaluated for uncoated tablets and were found to be within I. P limits. The coating thickness and percentage
of coating applied for various tablets were also evaluated. The optimized coated tablets were further subjected to micro
drilling on the upper face to get 0.5 µm orifice diameter. All the tablets were further subjected to dissolution studies by
using USP apparatus II with 6.8 pH phosphate buffer as medium. These studies indicated that all the tablets were found to release the drug up to 12 hours, while coated tablets with orifice found to release the drug at zero order rate, which was
in good agreement with peppas n > 0.9.
Key words: Controlled release, micro drilling, osmotic pressure, verapamil hydrochloride


Download data is not yet available.

Article Details

How to Cite
Vidyadhara, S., Sasidhar, R. L. C., Rao, V. U. M., Babu, C. H. S., & Harika, D. L. (2014). Formulation and evaluation of verapamil hydrochloride osmotic controlled release matrix tablets. Asian Journal of Pharmaceutics (AJP), 8(2).


Thakor RS, Majmudar FD, Patel JK, Rajput GC. Osmotic drug delivery

systems current scenario. J Pharm Res 2010;34:771‑5.

Panchaxari MD, Navik VK, Anand P, Vinayak SM, Mayank MS. Oral osmotic

drug delivery system: An update. Int J Res Pharm Sci 2011;2:225‑36.

Gupta S, Ravindra PS, Rohitashva S, Renu K, Priyanka L. Osmotic pumps:

A review. Int J Clin Pharm 2011;6:1‑8.

Wakode R, Amrita B. Once a day osmotic drug delivery system for highly

water soluble Pramipexole. J Chem Pharm Res 2010;2:136‑46.

Theeuwes F, Swanson DR, Guittard G, Ayer A, Khanna S. Osmotic

delivery systems for the beta‑adrenoceptor antagonists metoprolol

and oxprenolol: Design and evaluation of systems for once‑daily

administration. Br J Clin Pharm 1985;19:69‑76S.

Sean CS. The complete drug reference. 34th ed. London, England:

Pharmaceutical Press; 2011.

Hardy JG. Release rates from Sustained‑Release buccal tablets in man.

J Pharm Pharmacol 1982;34:91‑5.

Hogan JE. Hydroxy propyl methyl cellulose sustained release technology.

Drug Dev Ind Pharm 1989;15:975‑99.

Shah AC. Gel‑matrix systems exhibiting bimodal controlled release for

oral delivery. J Control Release 1989;9:169‑75.

Wilson HC, Cuff GW. Sustained release of isomazole from matrix tablets

administered to dogs. J Pharm Sci 1989;78:582‑4.

Ozturk AG. Mechanism of release from pellets coated with an ethyl

cellulose‑based film. J Control Release 1990;14:203‑13.

Narisawa S. Porosity‑controlled ethyl cellulose film coating. IV.

Evaluation of mechanical strength of porous ethyl cellulose film. Chem

Pharm Bull 1994;42:1491‑5.

Debord B. Study of different crystalline forms of mannitol: Comparative

behaviour under compression. Drug Dev Ind Pharm 1987;13:1533‑46.

Molokhia AM. Aging of tablets prepared by direct compression of bases

with different moisture content. Drug Dev Ind Pharm 1987;13:1933‑46.

Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial

pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987. p. 182‑4.

Herbert AL. Pharmaceutical Dosage Forms. Tablets 2005;2:321‑9.

Indian Pharmacopoeia. Government of India, Ghaziabad: The Indian

Pharmacopoeia Commission;2010;2:701.